72066322RFA00008: USAID//Ethiopia - Quality Healthcare Activity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Ethiopia USAID-Addis Ababa notices from 2022.
Ethiopia USAID-Addis Ababa offered grants of up to $49.8 million (at least $49.8 million) to any type of organization. It expected to make about 8 awards worth $49.8 million in total. Applications closed on November 11, 2022.
From the official notice on Grants.gov, last changed October 29, 2022. Checked November 7, 2026.
- Award ceiling$49.8 million
- Award floor$49.8 million
- Total funding$49.8 million
- Expected awards8
- Cost sharingRequired
- Funding typeCooperative Agreement
Key dates
| Posted | September 16, 2022 |
|---|---|
| Deadline | November 11, 2022 |
| Archived by Grants.gov | November 30, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $49.8 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
USAID/Ethiopia intends to award a five-year assistance Activity entitled, “USAID Quality Healthcare'' to support an organization or group of organizations, from here on, known as “Applicant”, “Recipient” or “Consortium” who share the expressed public purpose of improving the quality of healthcare for better reproductive, maternal and child health outcomes. The overall goal of this Activity is to improve the reproductive, maternal, newborn, child, and adolescent health (RMNCAH) status of women, adolescent girls, and children by building the capacity of urban and peri-urban primary health care units (PHCU) and referral health facilities in planning and delivering client-centered, quality RMNCAH services. This award will be funded with maternal and child health, and family planning funding. Therefore, all proposed activities and interventions should directly contribute to improved RMNCAH services, uptake, and ultimately, improved RMNCAH outcomes. The Activity goal will be achieved through three key, interrelated objectives: 1) improving readiness of the health facilities to deliver client-centered, quality RMNCAH services. 2) strengthening management and accountability for quality RMNCAH services; and 3) restoration of health services in conflict-affected areas. The Activity will contribute to the quality improvement priorities of the Government of Ethiopia (GOE) as outlined in the Health Sector Transformation Plan (HSTP II: 2020-2025), the National Healthcare Quality and Safety Strategy (revised), and national RMNCAH strategies and guidelines. The Activity will be implemented in selected woredas (hereafter referred as districts) of five regions of Ethiopia, namely Amhara, Oromia, Sidama, Southern Nations, Nationalities and People’s (SNNP) and Southwest Ethiopia (SWE). It will build on the gains of USAID/Ethiopia historical investments over the past two decades through various awards including Integrated Family Health Program (IFHP), Maternal and Child Survival Program (MCSP), and Transform/Primary Health Care, awards. The Activity will also have strong links with existing USAID/Ethiopia health systems strengthening (HSS) investments addressing critical areas of human resource for health (HRH), supply chain management (SCM), and health information systems. These linkages will ensure comprehensive support to selected districts and health facilities to ensure delivery of quality health services for Ethiopian citizens.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72066322RFA00008 still open?
No. It closed on November 11, 2022.
Who can apply for USAID//Ethiopia - Quality Healthcare Activity?
Ethiopia USAID-Addis Ababa accepted applications from any type of organization.
What is the deadline for USAID//Ethiopia - Quality Healthcare Activity?
Closed November 11, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $49.8 million each. About $49.8 million in total across about 8 awards.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)